Lanepitant

N/A

Report date: 2022/05/18 12:02:01
NME

Base Information

Drug NameLanepitant
Drug Alias Name拉奈匹坦lanepitant dihydrochloride trihydrateLY-303870
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurokinin 1 receptor antagonists
TargetsNeurokinin 1 receptor
Therapy Area/IndicationsPainInflammationAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsPainInflammationAsthma

Other Information

ATC CodeN/A
Related LinksWikipedia